Skip to main content
Clinical Trials/NCT02468752
NCT02468752CompletedPhase 2

Mängden kvävgasbubblor i Blodet Efter Dykning Vid Syrgasandning jämfört Med Luftandning

Göteborg University2 sites in 1 country48 target enrollmentStarted: May 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
48
Locations
2
Primary Endpoint
Venous gas emboli

Study Overview

Brief Summary

Primary objective:

  • Assessment of venous gas emboli load post diving when breathing normobaric oxygen compared to air.

Secondary objective:

  • Assessment of fluid markers of central nervous system injury in blood post diving
  • Assessment of fluid markers of inflammation and endothelial dysfunction in blood post diving

Tertiary objective:

  • Assessment of DCS frequency

Detailed Description

This is a prospective, double blinded, randomized, cross-over study in Sweden. The study was performed in two different sets, each containing standardized dives in a wet hyperbaric chamber. The dives included movement on depth.

In each study set 16-32 professional divers performed no-decompression dives to a depth of 42 metres of seawater (msw). The gas used during the dives was compressed air.

After surfacing the divers breathed either normobaric oxygen or normobaric air on a demand mask. Timing of oxygen/air-breathing differed between study sets. The content of breathing gas was unknown to both divers and examining personnel.

Immediately post dive the divers were assessed using either transthoracic doppler ultrasound (TTD) or transthoracic 2-D ultrasound (TTE) to determine VGE load, time to VGE detection and VGE duration.

Signs of DCS were actively sought.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Professional diver
  • Fit to dive according to Swedish Navy standards

Exclusion Criteria

  • Not provided

Arms & Interventions

Air

Sham Comparator

Normobaric air breathing

Intervention: Air (Other)

Oxygen

Experimental

Normobaric oxygen breathing

Intervention: Oxygen (Drug)

Outcomes

Primary Outcomes

Venous gas emboli

Time Frame: 120 minutes

Kisman-Masurel grading

Secondary Outcomes

  • Inflammatory activity and endothelial dysfunction(120 minutes/ 48 hours)
  • Decompression sickness(24 hours)
  • Markers of central nervous system injury(120 minutes/ 48 hours)

Investigators

Sponsor
Göteborg University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nicklas Oscarsson

MD

Göteborg University

Study Sites (2)

Loading locations...

Similar Trials